Forsythiaside A alleviates liver fibrosis by regulating gut microbiota and inhibiting inflammation

Forsythiaside A (FTA) is the main bioactive component of traditional Chinese medicine Forsythia suspensa. There is a small amount of evidence that FTA has a certain potential in the treatment of liver disease. However, little is known about the therapeutic effect and molecular mechanism of FTA on liver fibrosis. The purpose of this study was to investigate the therapeutic effect of FTA on liver fibrosis and reveal its potential therapeutic mechanism.